R43HL165987

A wearable magnetocardiography imaging system - project summary. Recent studies have shown radiation therapy (RT) ablation to be a highly promising alternative therapy for patients with drug-refractory VT who are unable to undergo catheter-based ablation. Ideally, RT ablation is performed in conjunction with noninvasive electrophysiology (EP) imaging, such as ECG imaging (ECGI), so that the entire procedure is noninvasive. However, currently noninvasive EP imaging is much less accurate than RT and needs to be significantly improved to realize the full potential of RT ablation.

In this project, we propose to utilize magnetocardiography (MCG) to develop an MCG imaging (MCGI) system. In comparison to ECG, MCG provides fundamental advantages for source localization and imaging due to the favorable transmission properties of magnetic signals. From a practical standpoint, MCG is more convenient because it is a contactless technique, whereas ECGI requires application of a large array of electrodes.

The proposed system will be based on a revolutionary type of magnetic sensor, known as an optically-pumped magnetometer (OPM), which was first brought to market by our company. OPMs are far more practical than SQUID magnetometers because they are smaller, less expensive, and operate at room temperature. This will enable construction of an MCGI system with a conformal sensor array that covers the entire torso.

The overall goal is to construct an MCGI system with improved accuracy and ease-of-use, compared to current ECGI/MCGI systems. The Phase I aims are to: 1) determine an optimal sensor configuration for the MCGI system based on analysis of the spatial properties of the signal, 2) design a compact magnetic shield that is patient-friendly and minimizes the space requirements of the system, 3) devise a strategy for rapid, accurate digitization of the sensor locations, and 4) demonstrate the feasibility of key aspects of the proposed techniques in a small study of normal subjects.

Quspin

TO FOSTER HEART AND VASCULAR RESEARCH IN THE BASIC, TRANSLATIONAL, CLINICAL AND POPULATION SCIENCES, AND TO FOSTER TRAINING TO BUILD TALENTED YOUNG INVESTIGATORS IN THESE AREAS, FUNDED THROUGH COMPETITIVE RESEARCH TRAINING GRANTS. SMALL BUSINESS INNOVATION RESEARCH (SBIR) PROGRAM: TO STIMULATE TECHNOLOGICAL INNOVATION, USE SMALL BUSINESS TO MEET FEDERAL RESEARCH AND DEVELOPMENT NEEDS, FOSTER AND ENCOURAGE PARTICIPATION IN INNOVATION AND ENTREPRENEURSHIP BY SOCIALLY AND ECONOMICALLY DISADVANTAGED PERSONS, AND INCREASE PRIVATE-SECTOR COMMERCIALIZATION OF INNOVATIONS DERIVED FROM FEDERAL RESEARCH AND DEVELOPMENT FUNDING. SMALL BUSINESS TECHNOLOGY TRANSFER (STTR) PROGRAM: TO STIMULATE TECHNOLOGICAL INNOVATION, FOSTER TECHNOLOGY TRANSFER THROUGH COOPERATIVE R&D BETWEEN SMALL BUSINESSES AND RESEARCH INSTITUTIONS, AND INCREASE PRIVATE SECTOR COMMERCIALIZATION OF INNOVATIONS DERIVED FROM FEDERAL R&D.

93.837 - Cardiovascular Diseases Research

National Heart Lung and Blood Institute (NHLBI) [HHS - NIH]

Colorado United States

State-Wide

PHS 2021-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) (PA-21-259)

Amendment Since initial award the End Date has been extended from 08/31/23 to 08/31/24.